Avanir Pharmaceuticals Inc. v. Par Pharmaceutical Inc.
612 F. App'x 613
CourtCourt of Appeals for the Federal Circuit
DecidedAugust 10, 2015
DocketNo. 2014-1838
StatusPublished
Cited by1 cases
This text of 612 F. App'x 613 (Avanir Pharmaceuticals Inc. v. Par Pharmaceutical Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Avanir Pharmaceuticals Inc. v. Par Pharmaceutical Inc., 612 F. App'x 613 (Fed. Cir. 2015).
Opinion
JUDGMENT
This Cause having been heard and considered, it is Ordered and Adjudged:
AFFIRMED. See Fed. Cir. R. 36.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Otsuka America Pharmaceutical, Inc. v. Hetero Labs Limited
Federal Circuit, 2026
Bayer Pharma AG v. Watson Laboratories, Inc.
212 F. Supp. 3d 489 (D. Delaware, 2016)
Cite This Page — Counsel Stack
Bluebook (online)
612 F. App'x 613, Counsel Stack Legal Research, https://law.counselstack.com/opinion/avanir-pharmaceuticals-inc-v-par-pharmaceutical-inc-cafc-2015.